← Leaderboards
Akiko Nishiyama
University Of Connecticut Storrs
$8,919,537
Attributed
$9,120,737
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,120,737 · 9
By mechanism
R01$8,063,918 · 4
S10$652,329 · 2
R21$402,401 · 1
P41$2,089 · 2
Top collaborators
- Dennis L Wright2 shared
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- Daniel K Mulkey$6,687,704
Others in their field
Top investigators on “Lesion”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$112,011,044
- Ronald T Mitsuyasu · University Of California Los Angeles$100,903,367
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,218,842
- John Anthony Baron · Dartmouth College$46,892,408
- C Kent Osborne · Baylor College Of Medicine$45,919,490
Research focus
LesionWhite MatterOligodendrogliaAffectRepairedOligodendrocyte LineageSignal TransductionPlayIn VivoDemyelinationsNeuraxisCspg4 GeneNeurogliaCell ProliferationBrainMultiple SclerosisCellsRemyelinationBaseNeuronsGeneticDemyelinating DiseasesNg2 AntigenChronic
Grant awards (32)
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival$338,475
R01 · FY2024 · NS · contact PI
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival$348,943
R01 · FY2023 · NS · contact PI
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival$348,943
R01 · FY2022 · NS · contact PI
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival$348,943
R01 · FY2021 · NS · contact PI
Homeostatic regulation of NG2 cell dynamics$337,235
R01 · FY2021 · NS · contact PI
SNARE complex-mediated exocytosis in oligodendrocyte differentiation and survival$348,943
R01 · FY2020 · NS · contact PI
Homeostatic regulation of NG2 cell dynamics$337,710
R01 · FY2020 · NS · contact PI
Homeostatic regulation of NG2 cell dynamics$338,158
R01 · FY2019 · NS · contact PI
Homeostatic regulation of NG2 cell dynamics$338,580
R01 · FY2018 · NS · contact PI
Homeostatic regulation of NG2 cell dynamics$338,979
R01 · FY2017 · NS · contact PI
Heterogeneity of NG2 Glial Cells$342,048
R01 · FY2016 · NS · contact PI
Heterogeneity of NG2 Glial Cells$342,001
R01 · FY2015 · NS · contact PI
Inflammation and NG2 Cell Differentiation$327,262
R01 · FY2015 · NS · contact PI
Leica TCS SP8 FSU AOBS 405 UV Spectral Confocal Microscope$456,323
S10 · FY2014 · OD · contact PI
Heterogeneity of NG2 Glial Cells$338,541
R01 · FY2014 · NS · contact PI
Inflammation and NG2 Cell Differentiation$324,405
R01 · FY2014 · NS · contact PI
Heterogeneity of NG2 Glial Cells$330,154
R01 · FY2013 · NS · contact PI
Inflammation and NG2 Cell Differentiation$316,596
R01 · FY2013 · NS · contact PI
Heterogeneity of NG2 Glial Cells$342,383
R01 · FY2012 · NS · contact PI
Inflammation and NG2 Cell Differentiation$328,453
R01 · FY2012 · NS · contact PI
Inflammation and NG2 Cell Differentiation$31,880
R01 · FY2012 · NS · contact PI
Inflammation and NG2 Cell Differentiation$321,849
R01 · FY2011 · NS · contact PI
Regulation of glial lineage by Olig2$219,968
R21 · FY2011 · NS · contact PI
Regulation of glial lineage by Olig2$182,433
R21 · FY2010 · NS · contact PI
Mechanisms of axon-NG2 cell interaction$324,515
R01 · FY2008 · NS · contact PI
Mechanisms of axon-NG2 cell interaction$318,404
R01 · FY2007 · NS · contact PI
Mechanisms of axon-NG2 cell interaction$20,367
R01 · FY2007 · NS · contact PI
Mechanisms of axon-NG2 cell interaction$321,201
R01 · FY2006 · NS · contact PI
NG2 GLIA-NEURONAL INTERACTION$1,009
P41 · FY2006 · RR · contact PI
Mechanisms of axon-NG2 cell interaction$308,950
R01 · FY2005 · NS
NG2 GLIA-NEURONAL INTERACTION$1,080
P41 · FY2005 · RR
BIORAD RADIANCE 2000 CONFOCAL IMAGING SYSTEM$196,006
S10 · FY2001 · RR